Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas.
Clin Cancer Res. 2021 Dec 1;27(23):6284-6286. doi: 10.1158/1078-0432.CCR-21-2935. Epub 2021 Sep 23.
Spatial single-cell transcriptomics of primary patient diffuse type gastric cancer reveals distinct cancer and stromal cell differences based on location. Expression of CCL2 by stromal cells in deep tumor regions is highlighted as potentially driving the immunosuppressive microenvironment and enhancing (directly or indirectly) the invasive capacity of tumor cells..
原发性弥漫型胃癌的空间单细胞转录组学研究揭示了基于位置的肿瘤细胞和基质细胞的明显差异。深肿瘤区域基质细胞表达的 CCL2 被突出为潜在的驱动免疫抑制微环境,并增强(直接或间接)肿瘤细胞的侵袭能力。